Alderaan Biotechnology
Latest round
- Series A
Last raised
- Mar 2022
Total raised
- $28M
Investors
- 2
About Alderaan Biotechnology
Based in Paris, France, and founded in 2017 by its CEO, Dr. Arnaud Foussat, and co-founders Armand Bensussa, and Daniel Olive, Alderaan Biotechnology operates as a company dedicated to the development of therapies for cancer treatment, with a specific focus on modulating immune cells. Alderaan Biotechnology developed CD25-specific monoclonal antibodies that deplete Treg cells from the tumor microenvironment while sparing effector T cells responsible for tumor destruction. Additionally, the company develops antibodies that target CD160-TM to enhance the cytotoxic activity of NK cells, leading to increased cancer cell destruction within the tumor and triggering an immune response against the tumor.
Who invested in Alderaan Biotechnology
2 investors across 4 rounds
See all investors in Alderaan Biotechnology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Alderaan Biotechnology
Who invested in Alderaan Biotechnology?
Alderaan Biotechnology has 2 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Alderaan Biotechnology raised?
Alderaan Biotechnology has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Alderaan Biotechnology last raise money?
Alderaan Biotechnology's most recent round on record is a Series A, in Mar 2022.
What does Alderaan Biotechnology do?
Based in Paris, France, and founded in 2017 by its CEO, Dr.
Where is Alderaan Biotechnology headquartered?
Alderaan Biotechnology is headquartered in Paris, France.
Which VCs invest in companies like Alderaan Biotechnology?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Alderaan Biotechnology's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Alderaan Biotechnology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.